EP4062916
Meðhöndlun á Fabry-sjúklingum sem hafa ákveðnar stökkbreytingar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.5.2018EP published:
9.10.2024EP application number:
22165669.7
EP translation filed:
6.1.2025Grant published:
15.2.2025EPO information:
European Patent Register
Max expiry date:
29.5.2038Expiry date:
29.5.2026Next due date:
31.5.2026
Title in English:
TREATING FABRY PATIENTS HAVING CERTAIN MUTATIONSLanguage of the patent:
English
Timeline
Today
30.5.2018EP application
9.10.2024EP Publication
6.1.2025Translation submitted
15.2.2025Registration published
29.5.2026Expires
Owner
Name:
Amicus Therapeutics, Inc.Address:
3675 Market Street, Philadelphia, PA 19104, US
Inventor
Name:
CASTELLI, JeffAddress:
Philadelphia 19104, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201762512458 PDate:
30.5.2017Country:
US
Number:
201862626953 PDate:
6.2.2018Country:
US
Classification
Categories:
A61K 31/445, A61P 13/12
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 9.5.2025
Expires: 29.5.2026
Payer: Árnason Faktor ehf.